English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

significance: a population-based study including 15,351 cases and Peripheral neuropathy and monoclonal gammopathy of undetermined Version 4 HAEMATOL/2019/239632 Haematologica Kristinsson Turesson, Magnus Björkholm, Ola Landgren, and Sigurður Yngvi Sæmundur Rögnvaldsson, Vilhjálmur Steingrímsson, Ingemar and Celgene. Other authors have no relevant conflicts-of-interest to disclose. has received research funding from: The International Myeloma Foundation (IMF), Amgen, Monitoring Committees (IDMCs) for clinical trials lead by Takeda, Merck, Janssen. SYK Celgene, Cellectis, Glenmark, Janssen, Juno, Pfizer; and serves on Independent Data Seattle Genetics, Karyopharm; Honoraria/ad boards: Adaptive, Amgen, Binding Site, BMS, Foundation, Rising Tides Foundation, Amgen, Celgene, Janssen, Takeda, Glenmark, Myeloma Foundation (IMF), Leukemia and Lymphoma Society (LLS), Perelman Family Administration (FDA), Multiple Myeloma Research Foundation (MMRF), International received research funding from: National Institutes of Health (NIH), U.S. Food and Drug submitted in partial fulfilment of the requirement for a PhD. Other disclosures: OL has Foundation (MMRF). SR is a PhD candidate at the University of Iceland and this work is the Perelman Family Foundation in collaboration with the Multiple Myeloma Research and publication was provided by the Memorial Sloan Kettering Core Grant (P30 CA008748) Research Fund, and Karolinska Institutet Foundations. For OL: funding support for this Research Fund, Icelandic Centre for Research (RANNIS), Landspitali University Hospital Funding: This research was supported by grants from the University of Iceland Disclosures:

haematologica

Peripheral neuropathy and monoclonal gammopathy of undetermined significance: a population-based study including 15,351 cases and 58,619 matched controls